Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Veeva Systems announced that Bristol Myers Squibb has implemented Veeva Vault CTMS globally to drive end-to-end trial management.
read more
Vectura Group plc announced it has signed an agreement with Incannex Healthcare Limited, an Australian cannabinoid medicines development company, to provide pre-clinical development services for IHL-216A, Incannex’s proprietary inhaled drug product ...
read more
Friday, December 05, 2014
VAXIMM AG, a Swiss-German biotech company focusing on oral cancer vaccines, announced today follow-on data from the first clinical trial of its investigational oral T-cell vaccine VXM01. Data of a trial extension of the randomized, placebo-controlled...
read more
Validant, a leading global quality, compliance and regulatory consulting group, has acquired Clinical Outcomes Solutions (COS), a global leader in clinical outcomes assessments (COA). COS was founded in 2013 and has developed a leadership position in...
read more
Thursday, October 07, 2021
Marken, the clinical trial logistics operation with UPS Healthcare, has expanded its global network to support increased demand for its clinical drug supply chain services, particularly for cell and gene clinical trials. Plans for the remainder of ...
read more
MRIGlobal and the University of Maryland School of Medicine today announced an intention to collaborate in the development of clinical specimen repositories, laboratory services for clinical trials, and research opportunities. The work will be ...
read more
United Drug plc, a leading international provider of healthcare services announces that it has reached agreement to acquire the UK and US clinical services businesses (combined "Bilcare Global Clinical Supplies" or "Bilcare GCS") from Bilcare Limited...
read more
uMotif, experts in patient-centered clinical solutions, announced its collaboration with Xperiome, a global health technology company specializing in rare diseases. The partnership will bring value to both life science companies conducting clinical ...
read more
Tuesday, October 20, 2020
Precigen announced the FDA clearance and successful technology transfer for its UltraPorator system, a proprietary software solution for the scale-up of rapid and cost-effective manufacturing of UltraCAR-T therapies.
read more
The March of 2013 grand opening of the Boca Raton Clinical Research (BRCR) facility in Lima, Peru was a significant event some 3,700 miles away.
read more
Thursday, October 24, 2019
TrialScope has acquired Clinical Trial Connect, a platform used by disease foundations and advocacy groups that connects their community members to relevant clinical trials.
read more
Trialogics, a clinical trial software and services company, providing eConsent, IRT (RTSM), and eCOA, announced that it is growing its overall services by expanding its Remote Device Management capabilities.
read more
The increasing need for speed and efficiency in clinical research has created more urgency to streamline and simplify the patient journey. Trialbee, a patient matching and enrolment platform, and uMotif, a patient-centric data capture provider, are ...
read more
Thursday, October 22, 2020
TRI has been awarded a contract to conduct the Randomized Master Protocol for Immune Modulators for Treating COVID-19 study under BARDA in collaboration with the NIH.
read more
Wednesday, January 19, 2022
Treadwell Therapeutics, a clinical stage, multi-modality biotechnology company developing novel therapeutics for highly aggressive cancers, and Genezen, a cell and gene therapy Contract Development and Manufacturing Organization (CDMO) have confirmed...
read more